The Intrinsic Value Podcast

The episode provides solid financial analysis with concrete metrics (Ferrari's P/E ratios, unit volumes, margin progression, Exor's NAV discount percentages) and frameworks for evaluating holding companies. However, much of the content revisits previously published research, and the discussion frequently circles back to well-established luxury brand principles rather than introducing novel patterns. The Lingado deep-dive adds some fresh substance, but padding from advertisements and repeated framings of the same thesis limits density.

“We expected earnings per share to be able to grow in the low double digits each year for several more years going forward”

“Ferrari just needs to perform decently while we wait for some mean reversion in exers discount to nav, probably driven by buybacks”

The episode applies standard value investing frameworks (discount-to-NAV analysis, luxury brand moat assessment, working capital evaluation) competently but without significant contrarian insight. The Exor/Ferrari thesis itself was pitched in prior episodes. The most original element - Lingado's performance and potential fee upside - receives limited treatment. The discussion of EV reception versus actual sales data shows some independent thinking, but overall the analysis confirms conventional wisdom about luxury resilience rather than challenging it.

“you can think of it as either getting a discount on Ferrari or paying full price for Ferrari, but getting a bunch of these other investments that they own on their balance sheet for free”

“Ferrari is a luxury brand and they're selling at a very different price point than a new Jeep”

Kyle Grieve and Sean O'Malley are experienced value investors with skin in the game, demonstrating genuine decision-making accountability by revisiting and defending an investment thesis that has underperformed. However, this is not a guest interview format; it's a portfolio review by the hosts themselves. The absence of external domain experts (Ferrari management, Exor insiders, or rival analysts) limits the episode's caliber in terms of bringing fresh practitioner perspective or being challenged by credible counterarguments.

“So we're going to update you on how the thesis has unfolded to hold ourselves, you know, accountable”

“I'm getting my chance to really, you know, dive deep into the thesis that they already built for me”

Strong on quantitative specifics: Ferrari's unit volumes (3,436 in Q1 2026), revenue per unit ($239k to $446k), P/E multiples (57x down to 30x), Exor's NAV discount (60% at entry, widening), Lingado's AUM tripling, specific stock performances (Carvana 42x, Teva 4x, Stellantis -48%). Weaker on forward guidance details and lacks direct quotes from earnings calls for some claims. CEO commentary is included but sparingly. The analysis relies heavily on published figures rather than proprietary data.

“Ferrari sold 3436 units in Q1 2026”

“revenue per unit has increased very drastically from about 239,000 to 446,000”

The hosts engage in genuine back-and-forth reasoning about kill criteria, process comparisons, and capital allocation trade-offs, showing intellectual honesty about uncertainty. However, questions often loop back to confirming the existing thesis rather than probing its weak points aggressively. The Process/Tencent analogy from Kyle is a strong push back, but Sean's response is somewhat defensive rather than deeply engaging with the counterargument. Few moments of productive disagreement; mostly collaborative reinforcement of the investment case.

“Did we mess this one up?”

“it is taking a long time for that gap to close. And I don't think it means yet that the thesis is broken”